 Annapolis Junction, Maryland, March 04, 2021 GLOBE NEWSWIRE -- Colfax Corporation NYSE: CFX, a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022. 